Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Emesyl is an over‑the‑counter homeopathic nasal spray marketed for rapid relief of nausea, including nausea related to motion sickness, pregnancy, vertigo, and medication side effects. It uses a proprietary intranasal delivery system intended to bypass gastrointestinal processing and provide fast systemic and local effects via the nasal mucosa. The product is positioned as non‑drowsy, non‑habit forming, and without known drug–drug interactions, and is sold directly to consumers in the United States by Itonis as a homeopathic drug product rather than an FDA‑approved conventional pharmaceutical.[3][7][10][11]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Emesyl Nausea Relief Nasal Spray.